Last reviewed · How we verify
NCT05968469
The Effects of Aerobic Exercise in Patients With Ankylosing Spondylitis
NA trial testing Aerobic exercises with cycling ergometry in Ankylosing Spondylitis in 56 participants. Completed in 12 January 2025.
21 October 2024
Quick facts
| Lead sponsor | Afyonkarahisar Health Sciences University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 56 |
| Start date | 30 July 2023 |
| Primary completion | 21 October 2024 |
| Estimated completion | 12 January 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Aerobic exercises with cycling ergometry
- Stretching exercises
Conditions studied
- Ankylosing Spondylitis — all drugs for Ankylosing Spondylitis →
- Aerobic Exercise — all drugs for Aerobic Exercise →
- Disease Activity — all drugs for Disease Activity →
Sponsor
Afyonkarahisar Health Sciences University
Who can join
Adults 20 to 60, any sex, with Ankylosing Spondylitis or Aerobic Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of our study is to investigate the effects of aerobic exercise and stretching exercises applied in high-intensity interval training protocol on disease activity, quality of life, spinal mobility and calprotectin, visfatin, leptin, IL-33 serum levels in patients with Ankylosing Spondylitis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05968469
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ankylosing Spondylitis
Currently open trials in the same condition.
- NCT07510789 — Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis · recruiting
- NCT07261644 — A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) · Phase 3 · recruiting
- NCT07390929 — Clinical Trial Study on the Improved New Method of Acupotomy for AS · NA · recruiting
- NCT06905288 — Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea. · recruiting
- NCT07166874 — The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis · NA · recruiting
Other Afyonkarahisar Health Sciences University trials
Trials by the same sponsor.
- NCT07482501 — Repetitive Transcranial Magnetic Stimulation in Cardiac Autonomic Dysfunction · NA · recruiting
- NCT07445594 — Effect of Play Dough, Slime, and Plush Toys on Dental Anxiety and Pain in Children During Dental Treatment · NA · not yet recruiting
- NCT07421206 — DETERMINATION OF THE EFFECTS OF STAINLESS STEEL CROWNS CEMENTED WITH RESIN CEMENTS ON INTERLEUKIN-10, 12, 18 LEVELS IN G · NA · not yet recruiting
- NCT07340385 — Physiological and Biochemical Responses to Blood Flow Restriction Training · recruiting
- NCT07312812 — The Effect of Art-Based Mandala Coloring Activity on Postpartum Anxiety and Postpartum Depression · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05968469 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Afyonkarahisar Health Sciences University
- Last refreshed: 14 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05968469.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing